Patents Assigned to TTS Pharma Ltd
  • Publication number: 20250381204
    Abstract: There is disclosed a composition comprising a cannabinoid and at least one terpene, wherein the terpene:cannabinoid ratio is 1:3 to 1:60. The composition in total comprises ?0.001% w/w of 9-tetrahydrocannabinol (THC) and <0.1% w/w of cannabigerol (CBG). There is also disclosed a composition comprising a cannabinoid and at least one terpene for use as a medicament. There is also disclosed a composition comprising a cannabinoid and at least one terpene for use in the treatment of anxiety and disorders associated with anxiety.
    Type: Application
    Filed: February 7, 2023
    Publication date: December 18, 2025
    Applicant: TTS PHARMA LTD
    Inventors: Mark TUCKER, Robert WALTON
  • Publication number: 20240122947
    Abstract: There is disclosed a composition comprising cannabidiol (CBD) and one or more cannabinoids selected from cannabidiolic acid (CBDA), cannabigerol (CBG) and cannabigerolic acid (CBGA) for use in the treatment or prevention of inflammation and disorders associated with inflammation or an IL-6 related disorder.
    Type: Application
    Filed: February 8, 2022
    Publication date: April 18, 2024
    Applicants: TTS Pharma Ltd, Aberystwyth University
    Inventors: Robert WALTON, Mark TUCKER, Debbie NASH, Nathan ALLEN, Ruth WONFOR, Ifat SHAH